Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis

MIR93 (microRNA -93) Regulates Tumorigenicity and Therapy Response of Glioblastoma by Targeting Autophagy

(2019) Tianzhi Huang et al.   Autophagy

The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells

(2019) Gal Mazor et al.   Cell Death & Disease

FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma

(2019) Zhenwei He et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis

(2019) Er-lin Song et al.   Aging-US

LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a

(2018) Hong Zhu et al.   BIOMEDICINE & PHARMACOTHERAPY

Functional Classification and Experimental Dissection of Long Noncoding RNAs

(2018) Florian Kopp et al.   CELL

LncRNA MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting SOX2

(2018) Zhiyong Xiong et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches

(2018) Nicola Amodio et al.   Journal of Hematology & Oncology

New insights into long noncoding RNAs and their roles in glioma

(2018) Zixuan Peng et al.   Molecular Cancer

LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations

(2018) Yongsheng Li et al.   NUCLEIC ACIDS RESEARCH

Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

(2018) Sabine Hombach-Klonisch et al.   PHARMACOLOGY & THERAPEUTICS

Elevated FUS/TLS expression is negatively associated with E‑cadherin expression and prognosis of patients with non‑small cell lung cancer

(2018) Dian Xiong et al.   Oncology Letters

SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis

(2018) Shuang Dai et al.   Frontiers in Pharmacology

Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling

(2018) Shule Xie et al.   MOLECULAR THERAPY

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

(2018) Xiaoyue Chen et al.   Nature Communications

Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma

(2018) Ningbo Xu et al.   Cell Death & Disease

A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma

(2018) Maolei Zhang et al.   Nature Communications

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

(2017) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cell-Cycle Therapeutics Come of Age

(2017) Matthew Ingham et al.   JOURNAL OF CLINICAL ONCOLOGY

Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization

(2017) Delphine Garnier et al.   NEURO-ONCOLOGY

Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

(2017) Jian Teng et al.   NEURO-ONCOLOGY

CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide

(2017) Simran Kaur et al.   NEURO-ONCOLOGY

Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide

(2017) Sang-Soo Kim et al.   NUCLEIC ACIDS RESEARCH

Long non-coding RNAs act as regulators of cell autophagy in diseases

(2017) Zhijie Xu et al.   ONCOLOGY REPORTS

An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network

(2017) Yang Li et al.   Nature Communications

The Role of HOTAIR/miR-148b-3p/USF1 on Regulating the Permeability of BTB

(2017) Libo Sa et al.   Frontiers in Molecular Neuroscience

An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas

(2017) Yuanliang Yan et al.   Frontiers in Molecular Neuroscience

Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment

(2016) Jin-Sung Park et al.   CANCER CELL

Long Noncoding RNAs in Cancer Pathways

(2016) Adam M. Schmitt et al.   CANCER CELL

Targeting autophagy to sensitive glioma to temozolomide treatment

(2016) Yuanliang Yan et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56

(2016) Abhinav K. Jain et al.   MOLECULAR CELL

RAID v2.0: an updated resource of RNA-associated interactions across organisms

(2016) Ying Yi et al.   NUCLEIC ACIDS RESEARCH

MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines

(2016) ZIRAN WANG et al.   ONCOLOGY REPORTS

Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling

(2016) Y Han et al.   Cell Death & Disease

LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer

(2016) Huan Wang et al.   Scientific Reports

TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer

(2015) Jun Li et al.   CANCER RESEARCH

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

(2015) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cancer RNA-Seq Nexus: a database of phenotype-specific transcriptome profiling in cancer cells

(2015) Jian-Rong Li et al.   NUCLEIC ACIDS RESEARCH

ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP

(2015) Shuying Sun et al.   Nature Communications

A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells

(2014) Jie Yao et al.   TUMOR BIOLOGY

mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma

(2011) Jessica I. Spitzer et al.   GENES CHROMOSOMES & CANCER

FUS/TLS Is a Co-Activator of Androgen Receptor in Prostate Cancer Cells

(2011) Simon Haile et al.   PLoS One